The AI-based methods using machine learning algorithms are effective in quickly screening a huge number of compound libraries and identifying molecules capable of modulating vital PD-related targets, including α-synuclein, GCase, and LRRK2 [6]. The gene discussed is LRRK2; the disease is Parkinson disease.